This is an index of side effect / adverse reaction reports (a.k.a. adverse event reports) related to Bleomycin and submitted to the FDA during the sample period of about a year. The information is not vetted and should not be considered as verified clinical evidence.
Reports by Event Outcome
All Cases (37)
Death (8)
Disability (8)
Reports by Reaction Type
Respiratory Disorder (8),
Pulmonary Toxicity (5),
Pancytopenia (5),
Gastrointestinal Haemorrhage (3),
Pyrexia (3),
Blood Creatinine Increased (3),
Death (2),
Thrombocytopenia (2),
Bronchopulmonary Aspergillosis (2),
Histiocytosis Haematophagic (2),
Vomiting (2),
Nausea (2)
Below are a few examples of reports where side effects / adverse reactions may be related to Bleomycin. For a complete list or a specific selection of reports, please use the links above.
Possible Bleomycin side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-27
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Carboplatin
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cisplatin
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Cytarabine
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dacarbazine
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Dexamethasone Sodium Phosphate
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin HCL
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Doxorubicin HCL
Dosage: unk
Indication: Hodgkin's Disease
Etoposide
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Etoposide
Dosage: unk
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Gemcitabine Hydrochloride
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Ifosfamide
Dosage: unk
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Dosage: 2 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Rituximab
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Vinblastine
Dosage: 8 cycles
Indication: Hodgkin's Disease
Start date: 2006-01-01
Vinorelbine
Dosage: unk
Indication: Hodgkin's Disease
Start date: 2007-01-01
Possible Bleomycin side effects in 29 year old female
Reported by a physician from Hungary on 2012-08-21
Patient: 29 year old female
Reactions: Histiocytosis Haematophagic, Cytomegalovirus Infection
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Carboplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cisplatin
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Cytarabine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dacarbazine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Dexamethasone
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin HCL
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Doxorubicin HCL
Etoposide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Etoposide
Start date: 2007-01-01
Gemcitabine Hydrochloride
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Ifosfamide
Start date: 2007-01-01
Ifosfamide
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Rituximab
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Vinblastine Sulfate
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2006-01-01
Vinorelbine
Indication: non-Hodgkin's Lymphoma Stage IV
Start date: 2007-01-01
Possible Bleomycin side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13
Patient:
Reactions: Sepsis, Diffuse Large B-Cell Lymphoma Recurrent, Diffuse Large B-Cell Lymphoma
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Dosage: days 1 and 5
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Dosage: patients on r-chop received 750 mg/m2 on day 1; and acvbp received 1200 mg/m2
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: day 1,patients on r-chop recieved 50 mg/m2; and on acvbp received 75 mg/m2 on day 1
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Dosage: days 1 through 5
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: day 1, in r-chop regimen
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: day 1 in r-chop regimen
Indication: Diffuse Large B-Cell Lymphoma
Vindesine
Dosage: days 1 and 5
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Fluorodeoxyglucose F 18
Possible Bleomycin side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13
Patient:
Reactions: Death
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Dosage: days 1 and 5
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Dosage: day 1
Doxorubicin HCL
Dosage: day 1
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: day 1
Prednisone TAB
Dosage: days 1-5
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: day 1
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: day 1
Indication: Diffuse Large B-Cell Lymphoma
Vindesine
Dosage: days 1 and 5
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Fluorodeoxyglucose F 18
Possible Bleomycin side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-13
Patient:
Reactions: Diffuse Large B-Cell Lymphoma Recurrent, Myocardial Infarction
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Dosage: on day 1 and 5 in acvbp treatment
Indication: Diffuse Large B-Cell Lymphoma
Cyclophosphamide
Dosage: on day 1 in r-chop treatment
Cyclophosphamide
Dosage: in acvbp treatment
Indication: Diffuse Large B-Cell Lymphoma
Doxorubicin HCL
Dosage: r-chop or acvbp treatment
Indication: Diffuse Large B-Cell Lymphoma
Prednisone TAB
Dosage: on days 1-5 in r-chop or acvbp treatment
Indication: Diffuse Large B-Cell Lymphoma
Rituximab
Dosage: on day 1 in r-chop treatment
Indication: Diffuse Large B-Cell Lymphoma
Vincristine
Dosage: on day 1 in r-chop treatment
Indication: Diffuse Large B-Cell Lymphoma
Vindesine
Dosage: on day 1 and 5 in acvbp treatment
Indication: Diffuse Large B-Cell Lymphoma
Other drugs received by patient: Fluorodeoxyglucose F 18
Possible Bleomycin side effects in male
Reported by a physician from Greece on 2012-08-09
Patient: male
Reactions: Pulmonary Toxicity, Dyspnoea, Haemoptysis, Haemorrhage, Pancytopenia, Pyrexia, Bone Marrow Toxicity
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Bleomycin
Dosage: 30 mg, for 3 days
Indication: Testis Cancer
Cisplatin
Dosage: 50 mg/m2, days 1 and 2
Indication: Testis Cancer
Etoposide
Dosage: 165 mg/m2, days 1-3
Indication: Testis Cancer
Possible Bleomycin side effects in 28 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29
Patient: 28 year old female
Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Peripheral Sensorimotor Neuropathy, Carbon Monoxide Diffusing Capacity Decreased, Pancytopenia, Febrile Neutropenia, Hypoaesthesia, Paraesthesia, Coordination Abnormal, Gait Disturbance, Renal Failure Acute
Adverse event resulted in: hospitalization, disablity
Drug(s) suspected as cause:
Bleomycin
Dosage: 15 units/m2 over 24h on day2
Cisplatin
Dosage: 90 mg/m2 over 4h on day1
Indication: Ovarian Cancer
Cisplatin
Dosage: 45 mg/m 2
Cyclophosphamide
Dosage: 1000 mg/m2 over 60min on day 2
Indication: Ovarian Cancer
Cyclophosphamide
Dosage: 750 mg/m 2
Doxorubicin HCL
Dosage: 45 mg/m2 over 30min on day3
Indication: Ovarian Cancer
Doxorubicin HCL
Dosage: 30 mg/m 2
Etoposide
Dosage: 200 mg/m2 over 2h on day3
Indication: Ovarian Cancer
Etoposide
Dosage: 100 mg/m 2
Vinblastine
Dosage: 6mg/m2 over 30min on day1
Indication: Ovarian Cancer
Other drugs received by patient: Pegfilgrastim
Possible Bleomycin side effects in 24 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-28
Patient: 24 year old female
Reactions: Mucosal Inflammation, Cellulitis, Pancytopenia
Drug(s) suspected as cause:
Bleomycin
Dosage: 15 units/m2 over 24 hours on d2
Indication: Ovarian Cancer
Cisplatin
Dosage: 90 mg/m2, over 4h on d1
Indication: Ovarian Cancer
Cyclophosphamide
Dosage: 1000 mg/m2 over 60 min on d2
Indication: Ovarian Cancer
Doxorubicin HCL
Dosage: 45 mg/m2 over 30 min on d3
Indication: Ovarian Cancer
Etoposide
Dosage: 200 mg/m2 over 2h on d3
Indication: Ovarian Cancer
Vinblastine Sulfate
Dosage: 6 mg/m2 over 30 min on d1
Indication: Ovarian Cancer
Other drugs received by patient: Pegfilgrastim
Possible Bleomycin side effects in 54 year old male
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-21
Patient: 54 year old male
Reactions: Bronchopulmonary Aspergillosis, Neutropenia, Infection
Drug(s) suspected as cause:
Bleomycin
Dosage: 10 mg/m2, day 8
Indication: Chemotherapy
Cyclophosphamide
Dosage: 750 mg/m2, day1
Indication: Chemotherapy
Doxorubicin HCL
Dosage: 50 mg/m2, day1
Indication: Chemotherapy
Etoposide
Dosage: 200 mg/m2, day1-3
Indication: Chemotherapy
Prednisolone
Dosage: 100 mg, day1-14
Indication: Chemotherapy
Procarbacin
Dosage: 100 mg/m2, day 1-7
Vincristine
Dosage: 1.4 mg/m2, day1
Indication: Chemotherapy
Possible Bleomycin side effects in 35 year old male
Reported by a physician from Israel on 2012-05-29
Patient: 35 year old male
Reactions: Respiratory Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Bleomycin
Dosage: 10 mg/m2, for all 6 cycles of beacopp
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 650 mg/m2for 2 cycles of standard beacopp
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 1250 mg/m2 for 4 cycles of escalated beacopp
Doxorubicin HCL
Dosage: 25 mg/m2, m2for 2 cycles of standard beacopp
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 35 mg/m2, for 4 cycles of escalated beacopp
Etoposide
Dosage: 300 mg/m2, for 2 cycles of standard beacopp
Indication: Hodgkin's Disease
Etoposide
Dosage: 600 mg/m2, for 4 cycles of escalated beacopp
Prednisone TAB
Dosage: 280 mg/m2,for all 6 cycles of beacopp
Indication: Hodgkin's Disease
Procarbazine
Dosage: 700 mg/m2, for all 6 cycles of beacopp
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, for all 6 cycles of beacopp
Indication: Hodgkin's Disease
Possible Bleomycin side effects in 30 year old male
Reported by a physician from Israel on 2012-05-29
Patient: 30 year old male
Reactions: Pulmonary Toxicity, Respiratory Disorder
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bleomycin
Dosage: 10 mg/m2,for 6 cycles
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 650 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Etoposide
Dosage: 300 mg/m2,for 6 cycles
Indication: Hodgkin's Disease
Prednisone TAB
Dosage: 280 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 700 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Possible Bleomycin side effects in 45 year old female
Reported by a physician from Israel on 2012-05-25
Patient: 45 year old female
Reactions: Respiratory Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Bleomycin
Dosage: 10 mg/m2, for 6 cycles
Indication: Hodgkin's Disease
Cyclophosphamide
Dosage: 650 mg/m2, for 6 cycles
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2, for 6 cycles
Indication: Hodgkin's Disease
Etoposide
Dosage: 300 mg/m2, for 6 cycles
Indication: Hodgkin's Disease
Prednisone TAB
Dosage: 280 mg/m2, for 6 cycles
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 700 mg/m2, for 6 cycles
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2, for 6 cycles
Indication: Hodgkin's Disease
Possible Bleomycin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24
Patient:
Reactions: Hepatotoxicity
Drug(s) suspected as cause:
Bleomycin
Dosage: 10u/m2
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: on day 4
Indication: Hodgkin's Disease
Interferon Alfa
Dosage: daily for 3 days prior to chemotherapy and on day 4
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Possible Bleomycin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24
Patient:
Reactions: Vomiting, Nausea, Mental Disorder, Pyrexia, Asthenia, Hepatic Enzyme Increased, Hodgkin's Disease
Drug(s) suspected as cause:
Bleomycin
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin HCL
Indication: Hodgkin's Disease
Interferon Alfa
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Possible Bleomycin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-24
Patient:
Reactions: Pancytopenia
Drug(s) suspected as cause:
Bleomycin
Dosage: 10u/m2
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: on day 4
Indication: Hodgkin's Disease
Interferon Alfa
Dosage: daily for 3 days prior to chemotherapy and on day 4
Indication: Hodgkin's Disease
Vinblastine Sulfate
Indication: Hodgkin's Disease
Possible Bleomycin side effects in female
Reported by a health professional (non-physician/pharmacist) from Netherlands on 2012-05-22
Patient: female
Reactions: Premature Menopause
Drug(s) suspected as cause:
Bleomycin
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Vinblastine Sulfate
Indication: Hodgkin's Disease
Possible Bleomycin side effects in
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-22
Patient:
Reactions: Pulmonary Toxicity
Drug(s) suspected as cause:
Bleomycin
Dosage: 10u/m2 - cycle 3
Bleomycin
Dosage: 10u/m2 - cycle 1
Bleomycin
Dosage: 10u/m2 - cycle 5
Bleomycin
Dosage: 10u/m2 - cycle 2
Indication: Hodgkin's Disease
Bleomycin
Dosage: 10u/m2 - cycle 6
Bleomycin
Dosage: 10u/m2 - cycle 4
Dacarbazine
Dosage: cycle 2
Dacarbazine
Dosage: cycle 6
Dacarbazine
Dosage: cycle 3
Dacarbazine
Dosage: cycle 5
Indication: Hodgkin's Disease
Dacarbazine
Dosage: cycle 1
Dacarbazine
Dosage: cycle 4
Doxorubicin Hydrochloride
Dosage: 1 cycle
Indication: Hodgkin's Disease
Doxorubicin Hydrochloride
Dosage: cycle 5
Doxorubicin Hydrochloride
Dosage: cycle 2
Doxorubicin Hydrochloride
Dosage: cycle 4
Doxorubicin Hydrochloride
Dosage: cycle 3
Doxorubicin Hydrochloride
Dosage: cycle 6
Interferon Alfa
Indication: Hodgkin's Disease
Interferon Alfa
Dosage: given day 1-4
Interferon Alfa
Interferon Alfa
Interferon Alfa
Interferon Alfa
Vinblastine Sulfate
Dosage: cycle 1
Vinblastine Sulfate
Dosage: cycle 6
Indication: Hodgkin's Disease
Vinblastine Sulfate
Dosage: cycle 3
Vinblastine Sulfate
Dosage: cycle 5
Vinblastine Sulfate
Dosage: cycle 2
Vinblastine Sulfate
Dosage: cycle 4
Possible Bleomycin side effects in 30 year old male
Reported by a physician from Israel on 2012-05-21
Patient: 30 year old male
Reactions: Pulmonary Toxicity, Respiratory Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Bleomycin
Dosage: 10 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Cytoxan
Dosage: 650 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Etoposide
Dosage: 300 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Prednisone
Dosage: 280 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 700 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Possible Bleomycin side effects in 33 year old male
Reported by a physician from Israel on 2012-05-21
Patient: 33 year old male
Reactions: Respiratory Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Bleomycin
Dosage: 10 mg/m2
Indication: Hodgkin's Disease
Dacarbazine
Dosage: 375 mg/m2
Indication: Hodgkin's Disease
Dexamethasone
Dosage: 20mg
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2
Indication: Hodgkin's Disease
Vinblastine Sulfate
Dosage: 6 g/m2
Indication: Hodgkin's Disease
Possible Bleomycin side effects in 52 year old male
Reported by a physician from Israel on 2012-05-21
Patient: 52 year old male
Reactions: Pulmonary Toxicity, Respiratory Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Bleomycin
Dosage: 10 mg/m2
Indication: Hodgkin's Disease
Dacarbazine
Dosage: 375 mg/m2
Indication: Hodgkin's Disease
Dexamethasone
Dosage: 20mg
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2
Indication: Hodgkin's Disease
Vinblastine Sulfate
Dosage: 6 g/m2
Indication: Hodgkin's Disease
Possible Bleomycin side effects in 45 year old female
Reported by a physician from Israel on 2012-05-21
Patient: 45 year old female
Reactions: Respiratory Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Bleomycin
Dosage: 10 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Cytoxan
Dosage: 650 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Etoposide
Dosage: 300 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Prednisone
Dosage: 280 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Dosage: 700 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Vincristine
Dosage: 1.4 mg/m2 for 6 cycles
Indication: Hodgkin's Disease
Possible Bleomycin side effects in 26 year old female
Reported by a physician from Israel on 2012-05-21
Patient: 26 year old female
Reactions: Respiratory Disorder
Adverse event resulted in: disablity
Drug(s) suspected as cause:
Bleomycin
Dosage: 10 mg/m2
Indication: Hodgkin's Disease
Dacarbazine
Dosage: 375 mg/m2
Indication: Hodgkin's Disease
Dexamethasone
Dosage: 20mg
Indication: Hodgkin's Disease
Doxorubicin HCL
Dosage: 25 mg/m2
Indication: Hodgkin's Disease
Vinblastine Sulfate
Dosage: 6 g/m2
Indication: Hodgkin's Disease
Possible Bleomycin side effects in male
Reported by a physician from United States on 2012-05-16
Patient: male, weighing 73.8 kg (162.4 pounds)
Reactions: Lung Disorder, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bleomycin
Dosage: 152 unit
Dacarbazine
Dosage: 5746 mg
Doxorubicin Hydrochloride
Dosage: 384 mg
Vinblastine Sulfate
Dosage: 94 mg
Possible Bleomycin side effects in 42 year old male
Reported by a physician from Croatia (Local Name: Hrvatska) on 2012-05-14
Patient: 42 year old male, weighing 87.0 kg (191.4 pounds)
Reactions: Throat Irritation, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bleomycin
Dosage: 30 mg, unk
Indication: Testis Cancer
Start date: 2012-01-14
End date: 2012-01-18
Cisplatin
Dosage: 42 mg, unk
Indication: Testis Cancer
Start date: 2012-01-14
End date: 2012-01-18
Etoposide
Dosage: 210 mg, unk
Indication: Testis Cancer
Start date: 2012-01-14
End date: 2012-01-18
Possible Bleomycin side effects in
Reported by a physician from Italy on 2012-05-04
Patient:
Reactions: Death, Hodgkin's Disease Recurrent, Lung Disorder, Pulmonary Embolism, Treatment Failure, Lymphoma, Hodgkin's Disease
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin HCL
Indication: Hodgkin's Disease
Doxorubicin HCL
Epirubicin Hydrochloride
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Lomustine
Indication: Hodgkin's Disease
Mechlorethamine
Indication: Hodgkin's Disease
Prednisone TAB
Indication: Hodgkin's Disease
Procarbazine Hydrochloride
Indication: Hodgkin's Disease
Vinblastine
Indication: Hodgkin's Disease
Vincristine Sulfate
Indication: Hodgkin's Disease
Vindesine
Indication: Hodgkin's Disease
Possible Bleomycin side effects in 42 year old male
Reported by a physician from Croatia (Local Name: Hrvatska) on 2012-05-03
Patient: 42 year old male, weighing 87.0 kg (191.4 pounds)
Reactions: Throat Irritation, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bleomycin
Dosage: 30 mg, unk
Indication: Testis Cancer
Start date: 2012-01-14
End date: 2012-01-18
Cisplatin
Dosage: 42 mg, unk
Indication: Testis Cancer
Start date: 2012-01-14
End date: 2012-01-18
Etoposide
Dosage: 210 mg, unk
Indication: Testis Cancer
Start date: 2012-01-14
End date: 2012-01-18
Possible Bleomycin side effects in 50 year old male
Reported by a physician from Greece on 2012-05-02
Patient: 50 year old male
Reactions: Multi-Organ Failure, Toxicity To Various Agents
Adverse event resulted in: death
Drug(s) suspected as cause:
Bleomycin
Indication: Hodgkin's Disease
Dacarbazine
Indication: Hodgkin's Disease
Doxorubicin HCL
Indication: Hodgkin's Disease
Etoposide
Indication: Hodgkin's Disease
Ifosfamide
Indication: Hodgkin's Disease
Mesna
Indication: Hodgkin's Disease
Mitoxantrone Hydrochloride
Vinblastine
Indication: Hodgkin's Disease
Possible Bleomycin side effects in 69 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-23
Patient: 69 year old male
Reactions: Gastrointestinal Haemorrhage, Blood Creatinine Increased
Drug(s) suspected as cause:
Bleomycin
Dosage: 30000 iu, day 2
Indication: Testicular Germ Cell Cancer
Carboplatin
Indication: Testicular Germ Cell Cancer
Cisplatin
Dosage: 100 mg/m2, cyclic
Indication: Testicular Germ Cell Cancer
Etoposide
Dosage: 500 mg/m2, cyclic
Indication: Testicular Germ Cell Cancer
Possible Bleomycin side effects in 69 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-02-21
Patient: 69 year old male
Reactions: Gastrointestinal Haemorrhage, Blood Creatinine Increased
Drug(s) suspected as cause:
Bleomycin
Carboplatin
Indication: Testicular Germ Cell Cancer
Cisplatin
Etoposide
Possible Bleomycin side effects in 27 year old male
Reported by a physician from Portugal on 2012-02-15
Patient: 27 year old male
Reactions: Bronchopulmonary Aspergillosis, Lymphopenia, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Bleomycin
Indication: Testis Cancer
Cisplatin
Dosage: 1st-line: cycles every 21d, 2nd-line: cycles every 28d
Indication: Testis Cancer
Etoposide
Indication: Testis Cancer
Ifosfamide
Indication: Testis Cancer
Vinblastine Sulfate
Indication: Testis Cancer
|
